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Summary
Here, we report that a lipophilic derivative of glucosamine, Glu5, is able to prevent impact-induced chondrocyte death by the putative mech-
anism of reducing mitochondrial depolarisation following a single impact load in vitro.
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Osteoarthritis (OA) is the most prevalent musculoskeletal
disease in humans, causing joint pain, loss of motility and
signiﬁcantly reducing the quality of life of those affected.
At this time, no therapeutic treatment is available to fully
prevent the initiation or the progression of this disease, indi-
cating our lack of understanding of the molecular mecha-
nisms involved. In recent years, the chondro-protective
effects of glucosamine sulphate and chondroitin sulphate
have been tested to establish their possible disease modify-
ing OA drug (DMOAD) properties. However, the molecular
mechanisms of action of glucosamine are not fully
understood.
The ability of glucosamine-containing nutraceuticals to re-
duce proteoglycan loss, impede cartilage degeneration, slow
down joint space narrowing, and improve pain has been
extensively reported1e3. Furthermore, animal models have
found that glucosamine is able to reduce cartilage degrada-
tion following anterior cruciate ligament transection in rab-
bits4 and in cultured articular cartilage explants5. However,
other clinical trials have failed to observe beneﬁcial effects
of glucosamine, rendering glucosamine an encouraging
but controversial agent for the treatment of OA6.
Investigation of the molecular mechanisms underlying the
efﬁcacy of the glucosamines has been based on reports of
its ability in vitro to increase proteoglycan and collagen II
synthesis in a dose-dependent manner7 and decrease ma-
trix degradation through a number of putative mechanisms.
For example, glucosamine has been shown to reduce
cyclooxygenase-2 (COX-2) and inducible nitric oxide syn-
thase (iNOS) expression leading to reduced levels of pros-
taglandin E2n (PGE2) and nitric oxide (NO), two important
mediators of cartilage degradation8. It has been proposed*Address correspondence and reprint requests to: Dr M. E.
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125that this effect may be mediated through the inhibition of
the nuclear factor kappa B (NF-kB) signalling pathway by
glucosamine9. More recently, it has been suggested that
glucosamine increases extracellular matrix production via
upregulation of transforming growth factor - b1 (TGF-b1),
an endogenous mediator involved in the regulation of ana-
bolic and catabolic functions of chondrocytes10.Methods, results and discussion
Since chondrocyte death has recently been accepted as
a hallmark of OA11 and has been suggested as a causal
factor in the initiation of cartilage degradation12,13, this study
aimed to examine the effects of low doses of chemically
modiﬁed glucosamine on impact-induced chondrocyte
death using an established in vitro model of OA13. Cartilage
explants were collected from the proximal interphalangeal
joints of healthy horses (ages 2e22 years), subjected
to a single impact load and cultured in vitro as previously
described13. This impact protocol gives rise to secondary
OA-like cartilage damage and induces an OA-like pheno-
type, including death of a proportion of chondrocytes in
the superﬁcial zone of the cartilage13.
The glucosamine derivatives Glu5 and Glu11 were syn-
thesised and kindly donated by Prof C. McGuigan, Welsh
School of Pharmacy, University of Wales, Cardiff14. The
chemical modiﬁcations render Glu5 and Glu11 more lipo-
philic, and therefore more cell permeable. Explants were
pre-incubated for 3 h prior to impact-loading in culture me-
dium containing either dimethyl sulphoxide (DMSO) vehicle
only, 3 mM N-acetyl-glucosamine, 3 mM Glu5 or 3 mM Glu11.
Chondrocyte death was observed in the superﬁcial zone
of cartilage sections using terminal deoxynucleotidyl trans-
ferase - duTP nick-end labelling (TUNEL) (ApopTag kit,
Chemicon International, USA). When quantiﬁed 48 h fol-
lowing impact, a single impact load signiﬁcantly increased
apoptosis from 6.2% in unimpacted controls to 53.5%
(P< 0.001) [Fig. 1(A)]. Pre-incubation with N-acetyl-glucos-
amine prior to impact had no effect on chondrocyte viability
(P¼ 0.780). The impact-induced increase in cell death was
Fig. 1. Effect of a single impact load and pre-incubation with (A) N-
Glu and Glu5 and (B) N-Glu and Glu11 on the percentage TUNEL-
positive chondrocytes in the superﬁcial zone of cartilage explants
after 48 h in culture. Bars represent mean standard deviation
(SD). # Represents a signiﬁcant difference from 0 mm unimpacted
control and * represents a signiﬁcant difference from 50 mm im-
pacted untreated control treated with DMSO vehicle only (analysis
of variance-2 [ANOVA-2], P< 0.05).
Fig. 2. Effect of a single impact load and pre-incubation with culture
medium containing Glu5 on the percentage of superﬁcial chondro-
cytes with a JC-1 ratio larger than 0.9, indicating mitochondrial
depolarisation, after 6 h in culture. Bars represent mean SD.
# Represents a signiﬁcant difference from 0 mm unimpacted control
(ManneWhitney, P< 0.05).
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to impact (P< 0.001), although it remained signiﬁcantly
higher than the unimpacted control level (P< 0.001). Simi-
larly, when the experiment was repeated to determine the
effects of Glu11, a single impact load signiﬁcantly increased
apoptosis from 8.5% in unimpacted controls to 50.5%
(P< 0.001) [Fig. 1(B)]. Pre-incubation with N-acetyl-glucos-
amine prior to impact from a height of 50 mm had no effect
on chondrocyte viability (P¼ 0.806). Surprisingly, the im-
pact-induced increase in cell death was signiﬁcantly in-
creased to 86.0% by incubation with Glu11 prior to impact
(P< 0.001). This study is the ﬁrst to report a beneﬁcial ef-
fect of a glucosamine derivative in preventing chondrocyte
death. Albeit preliminary, this ﬁnding is of importance be-
cause it provides supportive evidence for the DMOAD cyto-
protective property of glucosamine. Although extensive
studies are still needed to elucidate the precise mechanism
of action of Glu5 within chondrocytes, some speculative
mechanisms are portrayed here. The site of action of Glu5
remains unknown, but is likely to be intracellular as this
chemically modiﬁed glucosamine is lipophilic and can there-
fore readily penetrate the chondrocyte plasma membrane.
In contrast, N-acetyl-glucosamine, its non-cell permeable
counterpart had no effect on preventing chondrocyte deathfollowing impact. The reduction in impact-induced cell death
achieved by Glu5 could be secondary to a reduction in
iNOS expression, similar to than seen with glucosamine
treatment8, as NO synthesis has been found to be involved
in chondrocyte death in cartilage degeneration15. Alterna-
tively, Glu5 could be acting in a similar way to hyaluronan
oligosaccharides, which have recently been described as
members of a new metabolic pathway, in which hyaluronan
is degraded by the lysosomes into small glucosamine-con-
taining oligosaccharides that are anti-apoptotic16.
Recently, it was discovered that impact-induced chondro-
cyte death is preceded by impact-induced mitochondrial de-
polarisation17. To determine the molecular mechanism by
which the glucosamine derivative Glu5 was able to reduce
impact-induced chondrocyte death, the effect of Glu5 on
impact-induced mitochondrial depolarisation was investi-
gated. Mitochondrial depolarisation was determined using
the ﬂuorescent probe 5,50,6,60-tetrachloro-1,10,3,30-tet-
raethyl-benzimidazoylcarbcyanine iodide (JC-1) (Molecular
Probes, Invitrogen Ltd., UK) as described previously17.
JC-1 ﬂuoresces red in polarised mitochondria, and green
when mitochondria become depolarised. Consequently, mi-
tochondrial depolarisation is indicated by an increase in the
green:red ﬂuorescence intensity ratio. Cells with an average
intensity ratio of 0.9 or above were considered to have de-
polarised mitochondria. Following culture for 6 h, the per-
centage of superﬁcial chondrocytes with a green:red
ﬂuorescence intensity ratio above 0.9, indicating mitochon-
drial depolarisation, was 6.7% (Fig. 2). This value was sig-
niﬁcantly increased in explants impacted from 50 mm to
39.4% (P¼ 0.014), but not by impacted explants pre-incu-
bated with Glu5 (12.9%; P¼ 0.362). However, when com-
paring impacted explants, no signiﬁcant difference was
found in the percentage of cells with a green:red ratio above
0.9 between explants pre-incubated with DMSO and those
pre-incubated with Glu5 (P¼ 0.108).
This preliminary result indicates that Glu5 may exert its
anti-apoptotic action post-mechanical insult by preventing
mitochondrial membrane depolarisation. A previous study
determined that impact-induced cell death is mediated
through the mitochondrial caspase-9 dependent apoptotic
pathway18. Glu5 could act either directly on the mitochon-
dria, or via one of the many pathways that lead to mitochon-
drial membrane depolarisation, such as reactive oxygen
127Osteoarthritis and Cartilage Vol. 16, No. 1species generation, or altered calcium signalling. Additional
work is needed to conﬁrm whether this mechanism is in-
volved as this could lead to the discovery of novel therapeu-
tic targets, and the production of further more active or more
speciﬁc chondro-protective compounds. Furthermore, the
actual percentage of chondrocyte death caused by a single
impact load should be conﬁrmed by experimental methods
other than TUNEL, as this technique has previously been
reported to overestimate apoptosis19.
One of the major advantages of glucosamine is that it is
safe, having no serious side-effects, even following treat-
ment with 100e200 the normal human dose for prolonged
periods as reported by Anderson et al.20. The chemically
modiﬁed glucosamines, being lipophilic, were used here
at relatively low concentrations. However, Glu11 was de-
signed to be more lipophilic and therefore more cell perme-
able than Glu5 and it is possible that due to its increased
lipophilic property, Glu11 was able to accumulate in chon-
drocytes at a much higher intracellular concentration than
Glu5, which may have been detrimental to chondrocyte me-
tabolism. It is of interest that high doses of glucosamine
(10e25 mg/ml, the equivalent of 38e96 mM) have previ-
ously been found to be detrimental to cartilage matrix and
chondrocyte viability, causing apoptosis in up to 90% of
chondrocytes21,22. Furthermore, an increase in the intracel-
lular levels of O-linked N-acetyl-glucosamine can lead to
cell death following cellular stress23, and it is therefore pos-
sible that supplementing cartilage with N-acetyl-glucos-
amine may stimulate that response. The cytotoxic effect
of Glu11 observed in this study further highlights the impor-
tance of elucidating the mechanisms of action of glucos-
amine and its derivatives upon chondrocytes, so that
a safe effective dose can be determined.
In conclusion, the results of this preliminary study indicate
that the elucidation of the mechanism of action of glucos-
amine and its derivatives in impact-induced cell death
may lead to the discovery of novel therapeutic targets,
and to the production of safe, active and speciﬁc com-
pounds for the treatment of OA.Acknowledgements
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